Vijay Gorantla to Immunomodulation
This is a "connection" page, showing publications Vijay Gorantla has written about Immunomodulation.
Connection Strength
0.224
-
Lin CH, Zhang W, Ng TW, Zhang D, Jiang J, Pulikkottil B, Lakkis F, Gorantla VS, Lee WP, Brandacher G, Zheng XX. Vascularized osteomyocutaneous allografts are permissive to tolerance by induction-based immunomodulatory therapy. Am J Transplant. 2013 Aug; 13(8):2161-8.
Score: 0.114
-
Fisher JD, Zhang W, Balmert SC, Aral AM, Acharya AP, Kulahci Y, Li J, Turnquist HR, Thomson AW, Solari MG, Gorantla VS, Little SR. In situ recruitment of regulatory T cells promotes donor-specific tolerance in vascularized composite allotransplantation. Sci Adv. 2020 03; 6(11):eaax8429.
Score: 0.046
-
Zhang W, Gorantla VS, Campbell PG, Li Y, Yang Y, Komatsu C, Weiss LE, Zheng XX, Solari MG. Biopatterned CTLA4/Fc Matrices Facilitate Local Immunomodulation, Engraftment, and Glucose Homeostasis After Pancreatic Islet Transplantation. Diabetes. 2016 Dec; 65(12):3660-3666.
Score: 0.036
-
Schneeberger S, Gorantla VS, Brandacher G, Zeevi A, Demetris AJ, Lunz JG, Metes DM, Donnenberg AD, Shores JT, Dimartini AF, Kiss JE, Imbriglia JE, Azari K, Goitz RJ, Manders EK, Nguyen VT, Cooney DS, Wachtman GS, Keith JD, Fletcher DR, Macedo C, Planinsic R, Losee JE, Shapiro R, Starzl TE, Lee WP. Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg. 2013 Feb; 257(2):345-51.
Score: 0.028